QT-interval parameters are potential indicators of increased cardiovascular risk. We evaluated prospectively their prognostic value, in relation to other risk markers, for cardiovascular fatal and nonfatal events in a cohort of 271 hypertensive type 2 diabetic outpatients. QT intervals were measured from 12-lead standard ECGs obtained on admission and maximum rate-corrected QTinterval duration and QT-interval dispersion (QTd) calculated. Clinical and laboratory data and 2-D echocardiograms (available in 126 patients) were recorded. Survival analyses included Kaplan-Meier survival curves, uni and multivariate Cox proportional-hazards models. After a median follow-up of 55 months (range 2-84), 68 total fatal or nonfatal cardiovascular events and 34 cardiovascular deaths (24 of them from cardiac causes) were observed. In multivariate Cox analysis, QTd was an independent predictor for total cardiovascular events (HR: 1.16, 95% CI: 1.01-1.34, for each 10 ms increments) and for cardiac deaths (HR: 1.28, 95% CI: 1.01-1.60). Other independent risk indicators for cardiovascular morbidity and mortality were echocardiographic left ventricular hypertrophy (Echo-LVH), serum triglycerides, presence of pre-existing cardiac and peripheral arterial disease, age, diabetes duration, heart rate and the presence of frequent ventricular premature contractions on ECG. The combination of QTd and Echo-LVH improved cardiovascular risk stratification compared with either alone, the presence of both prolonged QTd (465 ms) and Echo-LVH was associated with a 3.2-fold (95% CI: 1.7-6.1) increased risk of a first cardiovascular event and a 5.9-fold (95% CI: 2.1-16.4) increased risk of cardiovascular death. Thus, QT provided additive prognostic information for cardiovascular morbidity and mortality beyond that obtained from conventional risk markers, including Echo-LVH, in type 2 diabetic patients with arterial hypertension.
Introduction
Electrocardiographic QT-interval parameters are presumed to represent risk markers for the occurrence of life-threatening ventricular arrhythmias and thus potential predictors of cardiovascular mortality. 1 Indeed, they have been evaluated as prognostic factors in several pathological conditions, such as coronary heart disease, 2 heart failure, 3 other cardiomyopathies, 4 diabetes mellitus, 5 as well as in population-based studies, 6 with controversial results. 7 In patients with arterial hypertension, QT-interval parameters have mainly been associated with left ventricular mass (LVM). 8, 9 Only three studies [10] [11] [12] evaluated their usefulness as cardiovascular mortality risk indicators. We have previously reported 5 that two QT parameters, maximum heart ratecorrected QT-interval duration (QTcmax) and QTinterval dispersion (QTd) were prognostic factors for cardiovascular morbidity and mortality in the entire cohort of type 2 diabetic patients that included hypertensive and normotensive subjects, and also that QTcmax, but not QTd, was a specific predictor of future incident strokes 13 and of total mortality. 14 Thus, the aim of the present report was to investigate in a prospective study with up to 7 years of follow-up, the importance of these QT parameters for cardiovascular risk stratification in the subgroup of diabetic patients with arterial hypertension, and specifically, to assess if any QT parameter could provide additive prognostic information beyond that obtained by echocardiographically derived left ventricular hypertrophy, a well-established risk factor for cardiovascular morbidity and mortality. 15 
Materials and methods

Subjects and baseline procedures
Study subjects have been described elsewhere. 5, 16, 17 In brief, all adult type 2 diabetic outpatients that had standard ECGs recorded from July 1994 to June 1996 were enrolled in this prospective study. This protocol complied with the ethical guidelines of the Declaration of Helsinki, was approved by the local ethics committee and all participants gave written informed consent. From 471 patients included, 271 had arterial hypertension, defined by a mean casual office blood pressure measured during the first year of follow-up X140/90 mmHg or by being on any antihypertensive treatment. Blood pressure was measured twice in each visit, in the nondominant arm using a mercury manometer and a suitably sized cuff, with the patient in the sitting position after a minimum of 10-min rest. Systolic (SBP) and diastolic (DBP) pressures were considered as the first and fifth phases of Korotkoff sounds. Pulse pressures (PP) were calculated as SBP-DBP and mean arterial pressures (MAP) as DBP þ (PP/3). The baseline procedures and criteria for diagnosing clinical variables have also been detailed previously. 5, 16, 17 Laboratory evaluation included fasting plasma glucose, serum fructosamine, creatinine, triglycerides, total and HDL-cholesterol, and 24-h proteinuria, by automated methods.
Standard resting 12-lead ECGs were recorded in the same equipment and response frequencies at 25 mm/s paper speed and 10 mm/mV amplitude. Electrocardiographic abnormalities were registered according to the Minnesota code except criteria for LVH (ECG-LVH), which were either Sokolow-Lyon (SV1 þ RV5 or V6X3.5 mV) or Cornell sex-specific (SV3 þ RaVLX2.0 mV in women or 2.8 mV in men). ECG-LVH was established by a single independent observer unaware of other patient data. QT-interval durations were measured manually in every ECG lead where possible (a minimum of eight leads and three precordial ones was necessary), as previously described, 16 by a single-blinded observer. Two QTinterval parameters were obtained: maximum heart rate-corrected (by Bazett's formula) QT-interval duration (QTcmax) and QT-interval dispersion (QTd: difference between maximum and minimum noncorrected QT intervals 18 ). Mean relative intraobserver errors were 1.4% for QTcmax measurement and 12% for QTd (evaluated by remeasuring 30 randomly chosen ECGs).
Good-quality comprehensive 2D echocardiography were performed within 1 month of the admission ECG by the same experienced observer in 126 patients, as previously described. 17 Two-dimensionally guided M-mode images were obtained from the short axis parasternal view at the level of the tips of the mitral valve leaflets and the measurements of interventricular septal wall thickness (ISWT), posterior wall thickness (PWT) and left ventricular end diastolic diameter (LVEDD) were made at the peak of the ECG R wave according to the Penn convention. 19 Left ventricular mass (LVM) was calculated by the anatomically validated formula of Devereux and Reichek:
. Cutoff values for the presence of echocardiographic LVH (Echo-LVH) were those from the Framingham study 20 (4198 g for women and 4294 g for men). Relative wall thickness (RWT) was measured as the ratio of 2 Â (PWT/LVEDD).
Follow-up and end points
Patients were evaluated regularly at least two times a year until June 2001. Those that failed to attend to the hospital were contacted annually to determine health status. The primary end points were the first fatal or nonfatal cardiovascular event, cardiovascular and strict cardiac deaths. All-cause mortality was a secondary end point for this report. Causes of death and incidence of nonfatal cardiovascular events during the follow-up period were ascertained and classified from medical records, death certificates and interviews with their attending physicians and families, by using a standard questionnaire reviewed by an independent observer. Causes of death were coded according to the International Classification of Diseases. Nonfatal cardiovascular events included acute myocardial infarctions (AMIs), myocardial revascularizations (either surgical or not), strokes, amputations above the ankle and lower limb revascularizations. Cardiac deaths were defined as those due to AMI, progressive heart failure and sudden death (defined as death occurring instantaneously or within 1 h after the onset of symptoms). Cardiovascular mortality included all cardiac deaths plus fatal strokes (defined as death within 28 days of the index event) and fatal aortic and peripheral arterial disease events. The observation period for each patient was the number of months from the date of the measured ECG to the date of death (or the date of the first nonfatal cardiovascular event) or June 30, 2001 . In all, 21 patients (7.7%) were lost from follow-up and were considered censored observations at the date of their last hospital visit.
Statistical analysis
All statistics were performed using the STATA statistical package. Continuous data were described as medians and 5th and 95th percentile values. QT-interval variables were evaluated as continuous ones and also dichotomized at the upper quartile values (470 ms 1/2 and 65 ms, respectively for QTcmax and QTd). Survival analyses were performed by Kaplan-Meier estimation of survival curves (compared by log-rank tests) and by univariate and multivariate proportional-hazards Cox models. Serum creatinine was log 10 transformed before its inclusion in the models due to its positive skewed distribution. Missing data were frequent for 24-h proteinuria (21%), HDL-cholesterol (27%) and echocardiographic measurements (53%). It has been demonstrated that deleting subjects with a missing value on one of the predictor variables included in the multivariate models (the so-called completecases analysis) commonly leads to biased results and surely to loss of power. 21 So, in order to decrease bias and increase statistical efficiency, we imputed missing data using the expectation maximization method, that is based on the correlations between each variable with missing values and all other variables as estimated from the complete cases. We also performed complete-cases multivariate survival analyses and presented the results for comparison with the imputed data analyses. First, a baseline multivariate Cox regression model was fitted for each primary end point, entering all variables that showed in univariate analysis a probability value o0.10 in a stepwise forward procedure, except QT-interval parameters and Echo-LVH. Subsequently, improvements in the predictive model fitting were evaluated by entering either QTcmax or QTd simultaneously with Echo-LVH. Yet, to evaluate the complimentary prognostic information provided by QT-interval parameters and Echo-LVH, a combined test variable was derived that incorporate both measures into three categories: both nonprolonged QT parameter and absent Echo-LVH, either prolonged QT parameter or Echo-LVH present, and both prolonged QT parameter and Echo-LVH present. Assumptions of the proportional-hazards models and interactions were also tested 22 and no violation or significant interactions were observed. Results were presented as hazard ratios (HR) with 95% confidence intervals (95% CI). A two-tailed probability value o0.05 was regarded significant.
Results
Baseline characteristics and follow-up end points
After a median follow-up of 55 months (range 2-84 months), 68 first fatal or nonfatal cardiovascular events were observed: 20 AMIs (six fatal), 25 strokes (seven fatal), 12 other cardiac deaths (four due to progressive heart failure and eight sudden deaths), four myocardial revascularizations, five amputations, one lower limb revascularization and one death due to aortic rupture. There were 72 all-cause deaths, 34 cardiovascular deaths and 24 cardiac deaths (12 sudden deaths, eight deaths due to AMI and four due to progressive heart failure). Table 1 lists the baseline characteristics of patients with and without a first major cardiovascular event. Patients lost to follow-up had baseline characteristics identical to those with complete follow-up. Patients with complete echocardiographic data, except for having a slightly lower heart rate (75.6714.2 vs 79.4714.2 bpm, P ¼ 0.006) and a lower prevalence of retinopathy (13.1 vs 26.2%, P ¼ 0.012), had baseline characteristics similar to those with missing echocardiographic data. Also, the incidence of fatal and nonfatal end points during follow-up were identical between patients with and without complete echocardiographic data. Table 1 also presents the results of univariate proportional-hazards Cox analysis. The variables most strongly associated with cardiovascular morbidity were diabetes duration, presence of preexisting cardiac or peripheral arterial disease, serum triglycerides and HDL-cholesterol, heart rate and left ventricular mass. Pulse pressure was the only component of blood pressure univariately associated with cardiovascular events and both QTcmax and QTd also showed significant univariate associations. Figure 1 shows Kaplan-Meier estimation of survival curves for the three main end points with patients divided according to upper quartile value of QTd. These subgroups of patients had significantly different event-free survivals. On the other hand, QTcmax was not capable of distinguishing two subgroups with different prognoses (log-rank test P ¼ 0.07 for total cardiovascular events and P ¼ 0.20 for cardiovascular mortality). Table 2 presents the results of multivariate Cox survival analysis using only those 126 patients with complete data and Table 3 presents the results using imputed values for missing echocardiographic data (271 patients). The complete-cases analysis was not performed for cardiac mortality due to the small number of end points (12 cardiac deaths). In both analyses, the inclusion of QTd into the models added prognostic information for total fatal or nonfatal cardiovascular events and also for cardiac mortality in the imputed data analysis, but not for cardiovascular mortality. For each increment of 10 ms in QTd, there was an associated 16-24% excess risk of a first major cardiovascular event and a 28% excess risk of cardiac death, after adjustment for other significant cardiovascular risk factors. Echo-LVH also provided significant prognostic information for the three primary end points, its presence implied a three-to four-fold increased risk of cardiovascular death. Other predictors of cardiovascular morbidity and mortality were serum triglycerides, presence of pre-existing cardiac and peripheral arterial disease, age, baseline heart rate, diabetes duration (only for total cardiovascular events) and the presence of frequent premature ventricular contractions on baseline ECGs (for cardiovascular and cardiac deaths).
Survival analyses
For all-cause mortality, neither QT-interval parameter nor echocardiographic LVM or hypertrophy provided additional independent prognostication in multivariate analysis. The independent predictors of all-cause deaths were the presence of prior peripheral arterial disease (HR: 3.61, 95% CI: 1.98-6.58, Po0.001), older age (HR: 1.64, 95% CI: 1.25-2.16, Po0.001, for 10-years increments), higher heart rate (HR: 1.28, 95% CI: 1.10-1.49, P ¼ 0.001, for 10 bpm increments), increased proteinuria (HR:
1.16, 95% CI: 1.06-1.27, P ¼ 0.001, for increments of 1 g/24 h), the presence of frequent PVCs on ECGs (HR: 2.68, 95% CI: 1.34-5.39, P ¼ 0.006) and the use of beta-blockers that had a borderline protective effect (HR: 0.14, 95% CI: 0.03-1.03, P ¼ 0.053).
The effect of combining QTd and Echo-LVH prognostic informations is presented in Figure 2 and in Table 4 . After adjustment for other predictors of cardiovascular morbidity and mortality, the presence of both prolonged QTd and Echo-LVH was associated with a three-fold increased risk of a first major cardiovascular event and a nearly six-fold increased risk of cardiovascular death.
Discussion
The main finding of this prospective study with up to 7 years of follow-up is that prolonged QTd added prognostic information for cardiovascular morbidity and mortality beyond that obtained by other con- [10] [11] [12] have addressed this question. The first 10 involved 214 hypertensives followed up for a mean of 42 months and observed 24 all-cause deaths and 17 cardiac deaths. Although increased QTd was associated with total and cardiac mortalities in univariate analysis; only age, increased LVM and the presence of nonsustained ventricular tachycardia on 24-h Holter monitoring were independent predictors of death in multivariate analysis. The second study 11 evaluated 59 previously untreated hypertensive patients followed up for a mean of 119 months and observed only 12 deaths, six of them sudden deaths. As in the previous report, LVH and complex ventricular arrhythmias on Holter were associated with cardiac mortality. The present investigation had a greater number of patients and of fatal end points than these previous studies, also addressed nonfatal major cardiovascular events as a primary end point and was the first to evaluate the effect of the combination of QT parameters and Echo-LVH on survival . Also, both previous studies 10, 11 included the prognostic information derived from 24-h Holter monitoring, which was unavailable in the present one. Otherwise, we can speculate that possibly the presence of frequent premature ventricular contractions on baseline ECGs, demonstrated here to be the most important predictor of cardiovascular and cardiac mortalities, could provide prognostic information equivalent to the presence of high-grade ventricular arrhythmias on Holter monitoring. Yet, in this report all patients had type 2 diabetes, in opposition to the previous studies that included mainly hypertensives without comorbid conditions. These differences probably explain our findings in relation to those previous two investigations. The third study, 12 recently reported from the LIFE study investigators, indeed supported our findings, demonstrating that an electrocardiographic QT-interval parameter, maximum rate-corrected QT apex interval duration, was an independent predictor of all-cause and cardiovascular mortality in a population of hypertensives with electrocardiographic LVH. In particular, this report 12 also demonstrated that QT dispersion (calculated as the standard deviation of all QT intervals measured) was a predictor of the composite end point of cardiovascular deaths, nonfatal myocardial infarctions and nonfatal strokes, similar to our findings in regard to cardiovascular fatal and nonfatal events. However, opposite to our investigation, this study 12 had not adjusted their data to Echo-LVH, nor had evaluated the effect of combining both prognostic informations.
QTD is no longer believed to represent regional inhomogeneity of ventricular repolarization, as originally proposed. 18 Several recent reports 23, 24 Figure 2 Kaplan-Meier survival curves for the three primary end points in patients grouped according to combination criteria of QTd and Echo-LVH (LVHÀ and LVH þ indicate, respectively, absence and presence of Echo-LVH).
have demonstrated that it probably represents a crude and rather imprecise measurement of abnormalities of the whole course of ventricular repolarization, usually reflected by an altered, more complex, spatial vectorcardiographic T-wave loop. 7 Global abnormal patterns of ventricular repolarization are expected to occur not only in the hypertrophied myocardium with increased interstitial collagen deposition, but also secondary to myocardial ischaemia due to diminished coronary reserve or silent coronary artery disease and to cardiac autonomic denervation, conditions frequently present in hypertensive diabetic patients, 25 thus creating a functional substrate for an increased risk of arrhythmogenicity. Prolonged QTd, by reflecting these abnormalities of ventricular repolarization, may indeed constitute an indicator of this increased risk of life-threatening arrhythmias and sudden death, known to be present in hypertensive patients with left ventricular hypertrophy 26 and in diabetic patients. 27 The additive prognostic value of ventricular repolarization abnormalities, quantified by a different method (computer-measured electrocardiographic ST-segment depression) was also recently demonstrated in a populationbased study, 28 supporting the importance of altered repolarization in stratifying cardiovascular risk. In the present report the absence of significant repolarization abnormalities (indicated by a QTd p65 ms) and of Echo-LVH identified a subgroup of patients with a relatively low 5-year risk of cardiovascular morbidity and mortality (crude total cardiovascular event rate of 4.9 per 100 person-years of follow-up and cardiovascular mortality rate of 1.5 per 100 person-years), whereas the presence of both conditions identified a subgroup with a greatly increased risk of 5-year cardiovascular morbi-mortality (total event rate of 14.0 per 100 person-years and cardiovascular mortality rate of 6.8 per 100 person-years). These figures support the value of combining QTd and Echo-LVH to improve cardiovascular risk stratification.
The other independent predictors of cardiovascular morbidity and mortality demonstrated here, Echo-LVH, presence of pre-existing cardiac and peripheral arterial disease, increased serum triglycerides, older age, higher baseline heart rate and longer duration of diabetes, are all well-established risk factors supported by reports in patients with arterial hypertension, 15,29 diabetes 30 or in population-based studies. 31 The importance of the presence of frequent PVCs on ECGs as a predictor of cardiovascular mortality, probably by reflecting myocardial electrical instability that triggers reentry ventricular arrhythmias, has been discussed previously.
This study has some limitations. Most important is the absence of any anthropometric measurement, so LVM was not indexed to body surface or height. This may have diminished the prognostic strength of Echo-LVH and increased that of QTd; because both, at least in part, share common prognostic informations for survival. Otherwise, using the cutoff values for Echo-LVH derived from the Framingham cohort, 20 we observed an adjusted three to four-fold excess risk of cardiovascular and cardiac deaths associated with Echo-LVH, a figure comparable to other studies with indexed LVM, 15, 28, 32 and also a better predictive performance than using LVM as a continuous variable. These findings suggest that possibly this limitation might not have influenced our results. Second, the strategy of imputing values for missing data must be discussed, as this issue is crucial to the conclusions of the study. Imputation of missing data is a recognized statistical method aiming to increase statistical power and to decrease bias due to deleting subjects with a missing value on one of the predictor variables included in multivariate analyses. 21, 33 As can be ascertained by comparing the results presented in Table 2 (the   Table 4 Results of multivariate Cox survival analysis using combined QTd and Echo-HVE, adjusted for the same variables listed in Tables 2 and 3. analysis including only the subjects with complete data) with those presented in Table 3 (the imputeddata analysis), the last did increase statistical efficiency, reflected by the 95% confidence intervals narrower than those obtained in complete-cases analysis, without altering the essence of the findings, that is both QTd and Echo-LVH provided independent prognostic information for total cardiovascular morbidity and mortality. Also, the imputed-data analysis, because it included all patients and end points, allowed the inclusion in the multivariate models of variables, such as the presence of cardiac and peripheral artery disease, that were not selected in the complete-cases analysis due to their relatively low prevalence. So, the hazard ratios obtained for QTd and Echo-LVH in the imputeddata analysis were further adjusted for the presence of these potentially important prognostic markers. Thus, we believe that the strategy of data imputation used in this study could have strengthened the results rather than inducing bias and misconceptions. Otherwise, it should be recognized that a nearly half missing data from echocardiography is a clear limitation of this study, even if adequately compensated by the data imputation approach.
Other potential limitations of this study include the lack of some possibly important prognostic variables, such as 24-h blood pressure monitoring, that has been demonstrated to be a better mortality risk indicator than casual office blood pressure; 34 microalbuminuria and smoking status. The effect of including these missing variables is uncertain. Finally, the well-known lack of standardization and poor reproducibility of QTd measurement should be mentioned.
In conclusion, this prospective study provided evidence that ventricular repolarization abnormalities, although quantified by the imprecise measurement of QTd, are prognostically important for cardiovascular morbidity and mortality in type 2 diabetic patients with arterial hypertension, and that in combination with echocardiographic LVM are capable of improving cardiovascular risk stratification. Future efforts should focus on new, more reliable and precise methods of assessing ventricular repolarization complexity and abnormalities, such as spatial T-wave axis deviation, 35 descriptors of T-wave morphology 36 or principal component analysis of T-wave vector, 37 as well as on intervention studies to verify whether these repolarization abnormalities could be modified to decrease cardiovascular risk.
